临界的需求和机会,以先进制造的冷注射剂的冷化注射剂
Alina Alexeenko1, Maxwell Korang-Yeboah2, Serguei Tchessalov3
1Purdue University, West Lafayette, IN, 47907, USA. alexeenk@purdue.edu.
Pharmaceutical research
|June 27, 2025
概括
对公共卫生至关重要的冷化药物面临着制造方面的挑战. 本文介绍了生产这些具有延长保质期的重要注射药物的解决方案.
科学领域:
- 制药技术 制药技术 制药技术
- 制造业 制造业 制造业 制造业 制造业
- 公共卫生 公共卫生
背景情况:
- 软化药物和生物制品对于公共卫生至关重要,为储存提供延长的保质期.
- 在必需药物清单中,超过70%的抗生素以冷化无菌粉末的形式供应.
- 许多新型疗法,包括免疫疗法,最初以冷凍形式推出,以加快患者的获取.
研究的目的:
- 为应对与冷化注射剂相关的当前制造挑战.
- 为改善冷解药物生产提出短期和长期的方法.
- 传播国家制药技术研究所和教育研讨会的发现.
主要方法:
- 该研究基于2024年1月举行的研讨会的发现.
- 讨论的方法论涉及短期和长期的制造解决方案.
- 专注于克服现有生产障碍的实际方法.
主要成果:
- 确定冷化注射制品生产中的关键制造挑战.
- 制定可行的策略,以减轻这些挑战.
- 为提高冷化工艺的效率和可靠性的框架.
结论:
- 应对制造业的挑战对于确保基本冷化药物的持续供应至关重要.
- 实施拟议的方法可以改善药物可用性和患者获取.
- 持续的研究和合作对于推进冷化技术至关重要.
相关概念视频
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...


